GOTHENBURG, Sweden, Dec. 8, 2020 /PRNewswire/ — Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders, today announces positive top line data from the ATTRACT COVID-19 trial with C21 (VP01). A webcast…
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
Pune-based Gennova Biopharmaceuticals Ltd has got conditional permission for phases 1 and 2 human clinical trial of its COVID-19 vaccine. The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial…
Four trial volunteers who got Pfizer’s COVID-19 vaccine developed Bell’s palsy
As the United Kingdom began administering people with the Pfizer-BioNTech vaccine, four people who got Pfizer’s coronavirus vaccine in the firm’s trial developed Bell’s palsy, a form of temporary facial paralysis, according to US regulators’ report on the shot. Food…
Enlivex reports positive interim data from Covid-19 therapy trial
Clinical-stage immunotherapy company Enlivex Therapeutics has reported positive interim data from the Phase II clinical trial of Allocetra in severe and critical Covid-19 patients. Clinical-stage immunotherapy company Enlivex Therapeutics has reported positive interim data from the Phase II clinical trial…
PureTech begins trial of oral molecule for Long COVID respiratory issues
Clinical-stage biotherapeutics company PureTech Health has initiated the global, Phase II trial of LYT-100 (deupirfenidone) in Long COVID respiratory complications and related Sequelae. Clinical-stage biotherapeutics company PureTech Health has initiated the global, Phase II trial of LYT-100 (deupirfenidone) in Long…
Senhwa Biosciences enrols first patient in Covid-19 investigational drug trial
Clinical-stage biopharma firm Senhwa Biosciences has enrolled the first patient in a Phase II investigator-initiated trial (IIT) of its anti-SARS-CoV-2 investigational drug, Silmitasertib, for treating Covid-19. Clinical-stage biopharma firm Senhwa Biosciences has enrolled the first patient in a Phase II…
Ampio’s inhaled Covid-19 drug trial advances to enrolment completion
Ampio Pharmaceuticals has announced that its AP-014 Phase I clinical inhaled Ampion study is proceeding to full open enrolment of Covid-19 patients with respiratory distress. Ampio Pharmaceuticals has announced that its AP-014 Phase I clinical inhaled Ampion study is proceeding…
Study shows metformin can significantly reduce COVID-19 death risks in women
University of Minnesota Medical School and UnitedHealth Group researchers found that metformin was associated with significantly reduced COVID-19 death risks in women in one of the world’s largest observational studies of COVID-19 patients. Metformin is an established, generic medication for…
Hackers target COVID-19 vaccine cold chain, IBM finds
A global phishing campaign has been targeting organizations associated with the distribution of COVID-19 vaccines since September 2020, IBM security researchers say. In a blog post, analysts Claire Zaboeva and Melissa Frydrych of IBM X-Force IRIS announced that the phishing…
EMA highlights link between hydroxychloroquine and psychiatric disorders
EMA’s safety committee (PRAC) has recommended updating the product information for all chloroquine or hydroxychloroquine-containing medicines following a review of all available data that confirmed a link between the use of these medicines and the risk of psychiatric disorders and…
